A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.
Serrano D, Lazzeroni M, Gandini S, Macis D, Johansson H, Gjerde J, Lien E, Feroce I, Pruneri G, Sandri M, Bassi F, Brenelli F, Luini A, Cazzaniga M, Varricchio C, Guerrieri-Gonzaga A, DeCensi A, Bonanni B.
Serrano D, et al. Among authors: feroce i.
Breast Cancer Res. 2013 Jun 20;15(3):R47. doi: 10.1186/bcr3439.
Breast Cancer Res. 2013.
PMID: 23786776
Free PMC article.
Clinical Trial.